+Compare
GILD
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$62.36
Change
+$0.55 (+0.89%)
Capitalization
78.22B

GILD Price Prediction, Gilead Sciences AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

GILD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for GILD turned positive on June 23, 2022. Looking at past instances where GILD's MACD turned positive, the stock continued to rise in 32 of 51 cases over the following month. The odds of a continued upward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GILD's RSI Indicator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 23, 2022. You may want to consider a long position or call options on GILD as a result. In of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

GILD moved above its 50-day moving average on June 22, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GILD crossed bullishly above the 50-day moving average on July 01, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

GILD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 211 cases where GILD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GILD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.925) is normal, around the industry mean (7.040). P/E Ratio (17.422) is within average values for comparable stocks, (85.534). Projected Growth (PEG Ratio) (0.533) is also within normal values, averaging (3.198). GILD has a moderately high Dividend Yield (0.046) as compared to the industry average of (0.026). P/S Ratio (2.865) is also within normal values, averaging (3.916).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GILD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

GILD is expected to report earnings to fall 28.77% to $1.51 per share on July 27

Gilead Sciences GILD Stock Earnings Reports
Q2'22
Est.
$1.51
Q1'22
Beat
by $0.32
Q4'21
Missed
by $0.90
Q3'21
Beat
by $0.89
Q2'21
Beat
by $0.13
The last earnings report on April 28 showed earnings per share of $2.12, beating the estimate of $1.80. With 5.21M shares outstanding, the current market capitalization sits at 78.22B.
AI
A.I.Advisor
published Dividends

GILD paid dividends on June 29, 2022

Gilead Sciences GILD Stock Dividends
А dividend of $0.73 per share was paid with a record date of June 29, 2022, and an ex-dividend date of June 14, 2022. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), Pfizer (NYSE:PFE), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 82.94B. The market cap for tickers in the group ranges from 226K to 472.39B. JNJ holds the highest valuation in this group at 472.39B. The lowest valued company is NEWG at 226K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -0%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -6%. OTSKY experienced the highest price growth at 6%, while MAYNF experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -10% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 19
P/E Growth Rating: 37
Price Growth Rating: 55
SMR Rating: 45
Profit Risk Rating: 60
Seasonality Score: -8 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
13600
Web
https://www.gilead.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUP6.700.36
+5.68%
Tupperware Brands Corp
ALGS1.250.04
+3.31%
Aligos Therapeutics
NEM61.171.50
+2.51%
Newmont Corp
BL68.011.41
+2.12%
BlackLine
ISEE9.40-0.22
-2.29%
IVERIC bio

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.89%
AMGN - GILD
52%
Loosely correlated
+0.92%
JNJ - GILD
43%
Loosely correlated
+1.13%
ABBV - GILD
41%
Loosely correlated
+0.42%
NVS - GILD
39%
Loosely correlated
-0.20%
BMY - GILD
39%
Loosely correlated
-0.21%
More